Latest News

1 - 5 of 14 items.
  • The British Pharmacopoeia and coronavirus (COVID-19)

    The British Pharmacopoeia, as part of the MHRA regulatory centre, is working closely with the Department of Health and Social Care and other healthcare partners on the COVID-19 outbreak. We are commit…

    30th March 2020

  • March update for BPCRS standards status now available

    March 2020 update for British Pharmacopoeia Chemical Reference Substances (BPCRS) standards status is now available. British Pharmacopoeia Reference Standards Status Please see the list above for BPCR…

    12th March 2020

  • Impact of the Coronavirus outbreak on BPCRS shipments

    Shipments of BPCRS products are currently not significantly impacted by the Coronavirus outbreak.  We are able to ship to all destinations including mainland China (except for Hubei Province). Thank y…

    20th February 2020

  • You said! We Did! What Next?

    At the British Pharmacopoeia, we are always looking for ways to improve the products we offer and the user experience online. We’re particularly interested in understanding your views about the impact…

    19th February 2020

  • Information for users of the British Pharmacopoeia during the Transition Period (01 February – 31 December 2020)

    Now the UK has left the EU, we would like to reiterate that the UK was a founding member of the Convention on the Elaboration of a European Pharmacopoeia and will continue to be a member of the Europe…

    18th February 2020